Prudential Financial’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Prudential Financial’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-46,880	Closed	-$200K	–	2522
2020 Q2	$200K	Buy	+46,880	New	+$285K	﹤0.01%	2267
2019 Q4	–	Sell	-425,579	Closed	-$3.92M	–	2538
2019 Q3	$3.92M	Sell	425,579 -220	-0.1%	-$2.08K	0.01%	1236
2019 Q2	$3.94M	Buy	425,799 +69,600	+20%	+$525K	0.01%	1267
2019 Q1	$2.29M	Hold	356,199	–	–	﹤0.01%	1543
2018 Q4	$3.39M	Buy	356,199 +58,340	+20%	+$878K	0.01%	1250
2018 Q3	$6M	Buy	297,859 +43,250	+17%	+$1.13M	0.01%	1111
2018 Q2	$7.43M	Buy	254,609 +51,520	+25%	+$1.59M	0.01%	1055
2018 Q1	$6.05M	Buy	203,089 +16,200	+9%	+$522K	0.01%	1090
2017 Q4	$6.06M	Buy	186,889 +7,129	+4%	+$233K	0.01%	1066
2017 Q3	$6.25M	Buy	+179,760	New	+$5.78M	0.01%	1053
2016 Q4	–	Sell	-10,520	Closed	-$250K	–	2442
2016 Q3	$250K	Buy	+10,520	New	+$198K	﹤0.01%	2173

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Prudential Financial's LJPC Position: Q3 2020 in Review

Prudential Financial sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2020, closing a stake of 46,880 shares — an estimated $200K sold.

Prudential Financial first reported a position in LJPC in Q3 2016 and held it in 11 quarters. The position peaked at $7.43M in Q2 2018. 64 funds tracked by Wall St. Rank hold LJPC as of Q3 2020.

Prudential Financial reported no remaining La Jolla Pharmaceutical Company position as of Q3 2020 after selling out during the quarter.
Prudential Financial sold 46,880 La Jolla Pharmaceutical Company shares in Q3 2020, an estimated $200K.
Prudential Financial first reported a position in La Jolla Pharmaceutical Company in Q3 2016 and held it in 11 quarters.
Prudential Financial's La Jolla Pharmaceutical Company position peaked at $7.43M in Q2 2018.
64 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2020.

Based on Prudential Financial's 13F filing for Q3 2020, filed 16 Nov 2020.